Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Greater Cannabis CO Inc
(OP:
GCAN
)
0.0005
UNCHANGED
Streaming Delayed Price
Updated: 3:29 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0005
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0005
Today's Range
0.0005 - 0.0005
52wk Range
0.0004 - 0.0015
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prenatal Cannabis Exposure Not Linked To Elevated Risk Of Autism And Oklahoma Court Rules Pregnant Moms Who Use It Are Not Breaking The Law
July 19, 2024
Maternal marijuana use is not related to an increased risk of autism spectrum disorder (ASD) in children who were exposed to cannabis in utero. That's according to newly published data in Autism...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Can Marijuana Treat Autism, OCD & Irritable Bowel Syndrome? Ohio Medical Panel Will Investigate
February 13, 2023
Ohio researchers want to learn more about the effects of medical marijuana on those with autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD) and irritable bowel syndrome, reported...
Via
Benzinga
Performance
YTD
-37.50%
-37.50%
1 Month
N/A
N/A
3 Month
-28.57%
-28.57%
6 Month
-28.57%
-28.57%
1 Year
-50.00%
-50.00%
More News
Read More
Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment
October 07, 2022
Via
Benzinga
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
October 07, 2022
From
The Greater Cannabis Company, Inc.
Via
GlobeNewswire
Cannabis Movers & Shakers: Coda Signature, Greater Cannabis Co., BioHarvest Sciences, Compass Pathways
December 06, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Greater Cannabis Partners with Shaare Zedek Scientific on Innovative Neuropsychiatric Cannabinoid Therapy
August 30, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.